Twelve Points Wealth Management LLC Trims Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Twelve Points Wealth Management LLC lowered its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 42,345 shares of the company’s stock after selling 1,231 shares during the quarter. VanEck Pharmaceutical ETF comprises approximately 1.1% of Twelve Points Wealth Management LLC’s portfolio, making the stock its 18th biggest position. Twelve Points Wealth Management LLC owned 0.63% of VanEck Pharmaceutical ETF worth $3,654,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of PPH. FMR LLC increased its position in VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after buying an additional 212 shares in the last quarter. Edge Financial Advisors LLC purchased a new stake in shares of VanEck Pharmaceutical ETF in the third quarter worth $263,000. Grimes & Company Inc. bought a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at $310,000. Harbour Investments Inc. raised its position in shares of VanEck Pharmaceutical ETF by 16.6% in the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after purchasing an additional 488 shares during the last quarter. Finally, Townsquare Capital LLC raised its position in shares of VanEck Pharmaceutical ETF by 3.8% in the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after purchasing an additional 130 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH stock opened at $88.85 on Wednesday. The company has a market capitalization of $581.08 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a one year low of $84.48 and a one year high of $99.51. The company’s 50-day moving average is $87.74 and its 200 day moving average is $91.90.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently declared a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were issued a dividend of $0.411 per share. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.